Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population

Porntip Intapiboon; Purilap Seepathomnarong; Jomkwan Ongarj; Smonrapat Surasombatpattana; Supattra Uppanisakorn; Surakameth Mahasirimongkol; Waritta Sawaengdee; Supaporn Phumiamorn; Sompong Sapsutthipas; Pasuree Sangsupawanich; Sarunyou Chusri; Nawamin Pinpathomrat

Vaccines (2021) - Comments
pubmed: 34960122 doi: 10.3390/vaccines9121375 issn: 2076-393x

Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat